Navigation Links
AllCells, LLC Named to Inc. Magazine's 500/5000 List of Fastest Growing Companies
Date:8/23/2012

EMERYVILLE, Calif., Aug. 23, 2012 /PRNewswire/ -- AllCells, LLC, a leading provider of hematopoietic tissues, primary cell products, and related services to the global life science industry today announced it has ranked 2,420 on the prestigious Inc. 500/5000 list of fastest growing companies. AllCells ranked 194 within the Health industry segment.

Inc. 500/5000 is an exclusive ranking of the nation's fastest growing private companies according to percentage revenue growth when comparing 2008 to 2011. Qualifying companies must be US-based, privately held, for profit, and independent as of December 31, 2011. Past honorees include Intuit, Microsoft, Timberland, Oracle, and other notable alumni.

AllCells' Founder & CEO, Jay Tong, MD, commented, "It's inspiring to be recognized on the prominent Inc. 500/5000 list of fastest growing companies. AllCells continues to grow because our employees continue to demonstrate a shared passion for delivering exceptional value to our customers. This has always been our top priority." Wayne Vaz, VP Corporate & Business Development added, "We've been working hard during the past 3 years to manage dramatic growth in a balanced way, adding key resources to virtually every part of our business. Today, the company is better poised for future growth, and being named to the Inc. 500/5000 list helps validate our strategic direction." 

Full press release available here: http://www.allcells.com/blog/allcells-llc-named-to-inc-magazines-5005000-list-of-fastest-growing-companies/

About AllCells, LLC
AllCells (www.AllCells.com) is a global biotechnology company founded in 1998 to provide researchers with a reliable supply of biologically relevant, consistent quality primary cells that enable the advancement of scientific research in the areas of cell biology, oncology, virology, hematology, infectious disease and stem cell research. By partnering with AllCells, investigators can dramatically reduce time needed to isolate cells with guaranteed consistency thereby improving the efficiency, accuracy and relevance of their research studies. AllCells is fully certified in accordance with local, state and federal requirements.

About Inc.
Founded in 1979 and acquired in 2005 by Mansueto Ventures, Inc. is the only major brand dedicated exclusively to owners and managers of growing private companies, with the aim to deliver real solutions for today's innovative company builders. For more information, visit www.inc.com.


'/>"/>
SOURCE AllCells, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. NPL named by Semta as a top training provider
2. Fish & Richardson Principals Named "Life Sciences IP Stars" for 2012 by LMG Life Sciences
3. Verenium Corporation Named One Of The 2012 Best Places to Work in San Diego
4. TREVENTIS Corporation Scientific Founder, Donald Weaver, MD, Named Sobey Chair in Alzheimers Disease Research, His Third Endowed Chair
5. WuXi PharmaTech Named a Top Ten Outsourcing Enterprise in China for Five Consecutive Years
6. AHEAD Named to UBM Channels Solution Provider 500 List
7. Fortis Vice President of Nursing Robert Anders Named Academy of Nursing Education Fellow by National League for Nursing
8. China Biologic Has Announced the Resignation of CFO Y. Tristan Kuo and Named Mr. Ming Yang as Interim CFO
9. Imaging Contract-Research Pioneer, Donald P. Rosen, MD, Named CEO of ACR Image Metrix™
10. Kimberly-Clarks Bob Stargel Named One of Savoy Magazines Top 100 Most Influential Blacks in Corporate America
11. Life Technologies Plant in Austin, Texas Named One of IndustryWeeks Top Ten Best Plants for 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... Calif. , June 23, 2016  The Prostate Cancer Foundation ... increasingly precise treatments and faster cures for prostate cancer. Members of the Class ... across 15 countries. Read More About the Class of ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today in ... patient who developed lymphedema after being treated for breast cancer benefitted from an injection ... for dealing with this debilitating, frequent side effect of cancer treatment. , ...
Breaking Biology Technology:
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... and BANGALORE, India , April 28, ... Systems, a product subsidiary of Infosys (NYSE: INFY ... announced a global partnership that will provide end ... use mobile banking and payment services.      (Logo: ... key innovation area for financial services, but it also plays ...
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
Breaking Biology News(10 mins):